Since VT1021 stimulates TSP-1 expression in MDSCs, which then binds to CD36 and CD47 receptors in tumor cells to shrink the tumor7, the CD36 and CD47 levels of patient tumors were examined through IHC. Here, CD47 is linked to neoplasm.